Compare Charter Communications Inc (CHTR) vs TG Therapeutics Inc (TGTX) Price & Performance

Charter Communications (CHTR) trades at $150.25, down 1.99% amid volatile broadband sector pressures. The stock shows mixed technical signals with bullish moving averages but overbought RSI readings. Fundamentally, CHTR maintains strong profitability with 9.05% net margins and attractive valuation at 4.1 P/E, though facing revenue declines and subscriber losses. Recent debt refinancing activities and aggressive buybacks highlight management's focus on capital structure optimization.

Investment outlook remains cautious despite deep value metrics. The 10.6% upside to consensus $166.18 target offers potential, but persistent broadband competition and high debt load ($93.2B) create headwinds. Mobile growth and network investments provide long-term catalysts, yet near-term subscriber trends warrant monitoring for sustained recovery.

TG Therapeutics (TGTX) trades at $49.66, up 1.02% on the day, with a bearish technical signal and recent earnings misses despite strong revenue growth. The company reported Q2 2026 revenue of $240 million and raised full-year BRIUMVI guidance to $950 million, but net income was impacted by manufacturing investments. Valuation ratios show a high P/E of 18.22 and EV/EBITDA of 56.26, while profitability metrics like ROE of 100.28% remain robust.

Outlook is mixed: strong product demand and raised revenue targets support growth, but earnings volatility and a bearish technical trend pose risks. Analyst consensus is bullish with an $63.75 price target, though legal investigations and competitive pressures require monitoring for stock investors.